CytomX Therapeutics, Inc. — All Filings
762 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001567619-18-007414 | Dec 6, 2018 | Nov 30, 2018 |
| CT ORDER | — | 9999999997-18-009038 | Nov 19, 2018 | — |
| CT ORDER | — | 9999999997-18-009035 | Nov 19, 2018 | — |
| S-3 | S-3 | 0001564590-18-027415 | Nov 6, 2018 | — |
| 8-K | 8-K FOR Q3 2018 EARNING RELEASE | 0001564590-18-027403 | Nov 6, 2018 | — |
| 10-Q | CTMX-2018-09-30-10-Q | 0001564590-18-027387 | Nov 6, 2018 | Sep 30, 2018 |
| 4 | FORM 4 | 0001567619-18-005082 | Nov 5, 2018 | Nov 1, 2018 |
| 4 | FORM 4 | 0001567619-18-005081 | Nov 5, 2018 | Nov 1, 2018 |
| 8-K | 8-K | 0001564590-18-024564 | Oct 22, 2018 | — |
| 4 | FORM 4 | 0001567619-18-003477 | Oct 2, 2018 | Oct 1, 2018 |
| 4 | FORM 4 | 0001567619-18-002232 | Sep 6, 2018 | Sep 4, 2018 |
| 4 | FORM 4 | 0001567619-18-002231 | Sep 6, 2018 | Sep 4, 2018 |
| 8-K | 8-K | 0001564590-18-020463 | Aug 8, 2018 | — |
| 10-Q | 10-Q | 0001564590-18-020448 | Aug 8, 2018 | Jun 30, 2018 |
| 4 | FORM 4 | 0001140361-18-035277 | Aug 2, 2018 | Aug 1, 2018 |
| 8-K | 8-K | 0001193125-18-219686 | Jul 17, 2018 | Jul 12, 2018 |
| 424B5 | 424B5 | 0001193125-18-217946 | Jul 13, 2018 | — |
| 424B5 | FILED PURSUANT TO RULE 424(B)(5) | 0001193125-18-215425 | Jul 10, 2018 | — |
| 8-K | FORM 8-K | 0001193125-18-215419 | Jul 10, 2018 | — |
| 4 | FORM 4 | 0001140361-18-031945 | Jul 9, 2018 | Jul 5, 2018 |
| 4 | FORM 4 | 0001140361-18-031810 | Jul 6, 2018 | Jul 3, 2018 |
| 4 | FORM 4 | 0001140361-18-031328 | Jul 3, 2018 | Jul 2, 2018 |
| 4 | FORM 4 | 0001140361-18-031327 | Jul 3, 2018 | Jul 2, 2018 |
| 4 | FORM 4 SUBMISSION | 0000899243-18-016824 | Jun 15, 2018 | Jun 13, 2018 |
| 4 | FORM 4 SUBMISSION | 0000899243-18-016823 | Jun 15, 2018 | Jun 13, 2018 |
| 3 | FORM 3 SUBMISSION | 0000899243-18-016821 | Jun 15, 2018 | Jun 13, 2018 |
| 4 | FORM 4 SUBMISSION | 0000899243-18-016820 | Jun 15, 2018 | Jun 13, 2018 |
| 4 | FORM 4 SUBMISSION | 0000899243-18-016816 | Jun 15, 2018 | Jun 13, 2018 |
| 4 | FORM 4 SUBMISSION | 0000899243-18-016814 | Jun 15, 2018 | Jun 13, 2018 |
| 8-K | 8-K | 0001564590-18-015683 | Jun 15, 2018 | Jun 13, 2018 |
| 4 | FORM 4 | 0001140361-18-027475 | Jun 5, 2018 | Jun 1, 2018 |
| 4 | FORM 4 | 0001140361-18-027474 | Jun 5, 2018 | May 31, 2018 |
| 8-K | 8-K | 0001193125-18-182602 | Jun 4, 2018 | — |
| 8-K | 8-K | 0001193125-18-170157 | May 22, 2018 | — |
| 8-K | 8-K | 0001564590-18-013786 | May 16, 2018 | — |
| 8-K | 8-K | 0001564590-18-012390 | May 9, 2018 | — |
| 10-Q | 10-Q | 0001564590-18-012382 | May 9, 2018 | Mar 31, 2018 |
| 4 | FORM 4 | 0001140361-18-021345 | May 2, 2018 | May 1, 2018 |
| 4 | FORM 4 | 0001140361-18-021344 | May 2, 2018 | May 1, 2018 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-18-134834 | Apr 26, 2018 | Jun 13, 2018 |
| 4 | FORM 4 | 0001140361-18-016993 | Apr 4, 2018 | Apr 2, 2018 |
| 4 | FORM 4 | 0001140361-18-015300 | Mar 27, 2018 | Mar 26, 2018 |
| 10-K/A | 10-K/A | 0001193125-18-082604 | Mar 14, 2018 | Dec 31, 2017 |
| 8-K | 8-K | 0001564590-18-004745 | Mar 7, 2018 | — |
| S-8 | S-8 | 0001193125-18-073612 | Mar 7, 2018 | — |
| 10-K | 10-K | 0001564590-18-004727 | Mar 7, 2018 | Dec 31, 2017 |
| 4 | FORM 4 | 0001140361-18-012114 | Mar 5, 2018 | Mar 2, 2018 |
| 4 | FORM 4 | 0001140361-18-012113 | Mar 5, 2018 | Mar 2, 2018 |
| 4 | FORM 4 | 0001140361-18-012009 | Mar 5, 2018 | Mar 1, 2018 |
| 4 | FORM 4 | 0001140361-18-012008 | Mar 5, 2018 | Mar 1, 2018 |